Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2010 | 52 |

Tytuł artykułu

Interactions with the serotonergic but not endocannabinoid system may contribute to the antinociceptive efficacy of γ-butyrolactone derivatives in mice

Warianty tytułu

Języki publikacji




Słowa kluczowe






Opis fizyczny



  • Department of Pharmacodynamics, Jagiellonian University, Medical College, Medyczna 9, 30-688 Cracow, Poland
  • Department of Pharmacodynamics, Jagiellonian University, Medical College, Medyczna 9, 30-688 Cracow, Poland
  • Department of Pharmacodynamics, Jagiellonian University, Medical College, Medyczna 9, 30-688 Cracow, Poland
  • Chair of Pharmaceutical Chemistry, Department of Physicochemical Drug Analysis, Jagiellonian University, Medical College, Medyczna 9, 30-688 Cracow, Poland


  • ADCOCK, J.J. 2009. TRPV1 receptors in sensitization of cough and pain reflexes. Pulm. Pharmacol. Ther. 22: 65-70.
  • BOKSA,J.,MOKROSZ,M.J.,CHARAKCHIEVA-MINOL,S.,TATARCZYŃSKA, E., KŁODZIŃSKA, A., WESOŁOWSKA, A., and S. MISZTAL. 2001. 2-H-and 2-acyl-9-{ω-[4-(2-methoxyphenyl) piperazinyl]- alkyl)-l,2,3,4-tetrahydro-β-carbolines as ligands of 5-HT1A and 5-HT2A receptors. Pol. J. Pharmacol. 53: 501-508.
  • BOKSA, J., CHARAKCHIEVA-MINOL, S., DUSZYŃSKA, B., BUGNO, R., KŁODZIŃSKA, A., TATARCZYŃSKA, E., CHOJNACKA-WÓJCIK, E., and A.J. BOJARSKI. 2003. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid l,2,3,4-tetrahydro-γ-carbolineswithl-(2-methoxyphenyl) piperazine moiety. Pol. J. Pharmacol. 55: 1013-1019.
  • BRUNTON, L.L., LAZO, J. S., PARKER, K. L., MURRI, N., and D. K. BLUMENTHAL [ed..], Goodman & Gilman’s the pharmacological basis of therapeutics, 11th edition. McGraw Hill, 2007.
  • DE Vries, D. J., and P. M. BLUMBERG. 1989. Thermoregulatory effects of resiniferatoxin in the mouse: comparison with capsaicin. Life Sci. 44: 711-715.
  • EDDY, N., and D. LEIMBACH. 1953. Synthetic analgesics. II. Dithienylbutenyl - and dithienylbutylamines. J. Phar¬macol. Exp. Ther. 107: 385—393.
  • FILIP, M., and M. BADER. 2009. Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol. Rep. 61: 761—777.
  • GILRON, I., PETE, C., WATSON, N., CAHILL, C.M., and D.E. MOULIN. 2006. Neuropathic pain: A practical guide for the clinician. CMAJ 175(3): 265-275.
  • JASMIN, L., WU, M.V., and P.T. OHARA. 2004. GABA puts a stop to pain. Curr. Drugs Targets CNS Neurol. Disord. 3: 487-505.
  • JEONG, C.Y., CHOI, J.I., and M.H. YOON. 2004. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur. J. Pharmacol. 502: 205-211.
  • KOŁACZKOWSKI, M., ZAJDEL, P., FHID, O., DUSZYŃSKA, B., TATARCZYŃSKA, E., and M. PAWŁOWSKI. 2005. Synthesis and 5-TH1A/5-HT2A activity of some butyl analogs in the group of phenylpiperazine alkyl pyrimido[2,l-f] theophyllines. Pharmacol. Rep. 57: 229-235.
  • LE BARS, D., GOZARIU, M., and S.W. CADDEN. 2001. Animal models of nociception. Pharmacol. Rev. 53: 597-652.
  • LEITE, C.E., MOCELIN, C.A., PETERSEN, G.O., LEAL, M.B., and F.V. THIESEN. 2009. Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity. Pharmacol. Rep. 61: 217—224.
  • LEPPERT, W. 2009. Tramadol as an analgesic for mild to moderate cancer pain. Pharmacol. Rep. 61: 978-992.
  • ŁUSZCZKI, J.J., and S.J. CZUCZWAR. 2007. Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy. Prog. Neuropsychopharmacol. Biol. Psychiatry 31: 529-538.
  • MCCLEANE, G. 2008. Antidepressants as analgesics. CNS Drugs 22: 139-156.
  • MUTSCHLER, E., and G. GEISSLINGER. Mutschler. Farmakologia i toksykologia. 2nd edition. Medpharm Polska, 2010.
  • OMOIGUI, S. 2007. The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3 - inflammatory profile of pain syndromes. Med. Hypotheses 69: 1169-1178.
  • PALUCHOWSKA, M., MOKROSZ, M.J., CHARAKCHIEVA-MINOL, S., DUSZYŃSKA, B., KOZIOŁ, A., WESOŁOWSKA, A., STACHOWICZ, K., and E. CHOJNACKA-WÓJCIK. 2003. Novel 4-alkyl-l- arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-IIT1A/5-HT2A/D2 receptor activity. Pol. J. Pharmacol. 55: 543-552.
  • PRZEWŁOCKI, R., and B. PRZEWŁOCKA. 2001. Opioids in chronic pain. Eur. J. Pharmacol. 429: 79-91.
  • ROHET, F., RUBAT, C., COUDERT, P., and J. COUQUELET. 1997. Synthesis and analgesic effects of 3-substituted 4,6-diaryl- pyridazine derivatives of the arylpiperazine class. Bioorg. Med. Chem. 4: 655-659.
  • SAŁAT, K. FILIPEK, B., WIĘCKOWSKI, K., and B. MALAWSKA. 2009. Analgesic activity of 3-mono-substituted derivatives of dihydrofuran-2-one in experimental rodent models of pain. Pharmacol. Rep. 61: 807-818.
  • SANTOS, A.R.S., GADOTTI, V.M., OLIVEIRA, G.L., TIBOLA, D., PASZCUK, A.F., NETO, A., SPINDOLA, H.M., SOUZA, M.M., RODRIGUES, A.L.S., and J.B. CALEXTO. 2005. Mechanism involved in the antinociception caused by agmatine in mice. Neuropharmacology 48: 1021-1034.
  • SASAKI, M., ISHIZAKI, K., OBATA, H., and F. GOTO. 2001. Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test. Eur. J. Pharmacol.424: 45-52.
  • SHANNON, H.E., and E.A. LUTZ. 2000. Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin (1A) receptors. Psychopharmacology 149: 93-97.
  • SUH, Y.G., and U. OH. 2005. Activation and activators of TRPV1 and their pharmaceutical implication. Curr. Pharm. Des. 11(21): 2687-2698.
  • ŚLADOWSKA, H., SABINIARZ, A., FILIPEK, B., KARDASZ, M., and D. MACIĄG. 2003. Synthesis and pharmacological properties of N, N-dialkyl(dialkenyl)amides of 7-methyl- 3-phenyl-1- [2-hydroxy-3-(4-phenyl-l-piper azinyDpropyl] - 2,4-dioxo-l,2,3,4-tetrahydropyrido-[2,3-d]pyrimidine-5- -carboxylic acid. Farmaco 58: 25-32.
  • VAKVEL, S.A., BRIDGEN, D.T., TAO, Q., THOMAS, B.F., MARTIN, B.R., and A.H. LICHTMAN. 2005. ∆9-Tetrahydrocannabinol accounts for the antinociceptive, hypothermie and cataleptic effects of marijuana in mice. J. Pharmacol. Exp. Ther. 314(1): 329-337.
  • VONVOIGTLANDER, P.F., LEWIS, R.A., and G.L. NEFF. 1984. Kappa opioid analgesia is dependent on serotonergic mechanisms. J. Pharmacol. Exp. Ther. 231: 270-281.
  • WOODS, A.J., STOCK, M. J., GUPTA, A.N., WONG, T.T.L., and P.L.R. ANDREWS. 1994. Thermoregulatory effects of resiniferatoxin in the rat. Eur. J. Pharmacol. 264: 125—133.
  • XING, J., Lu, J., and Li, J. 2008. Purinergic P,X receptors presynaptically increase glutamatergic synaptic transmi¬ssion in dorsolateral periaqueductal gray. Brain Res. 1208: 46-55.


Rekord w opracowaniu

Typ dokumentu



Identyfikator YADDA

JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.